ReNetX Bio

About:

ReNetX Bio is a technology platform help to restore function in patients who are suffering from spinal cord injuries, stroke and glaucoma.

Website: http://www.renetx.com/

Top Investors: Connecticut Innovations, Spring Mountain Capital, Wings for Life

Description:

ReNetX Bio first-in-class therapeutics to treat injury and damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI)and glaucoma.

Total Funding Amount:

$9.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)renetx.com

Founders:

Erika Smith, George Maynard

Number of Employees:

11-50

Last Funding Date:

2020-09-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai